Arabinda K. Das

A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

V.A. Miller, Arabinda K. Das, M. Rossi · Journal of Clinical Oncology · 2009 · 193 citations

Medicine, Oncology, Pharmacotherapy +8

AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme

Olivier Chinot, T. De La Motte Rouge, N. Moore et al. · Advances in Therapy · 2011 · 192 citations · Full text

Medicine, Oncology, Pharmacology +14

Metal speciation in solid matrices

Arabinda K. Das · Talanta · 1995 · 158 citations

Natural Sciences, Chemistry, Elemental Analysis +9

Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab

Whitney B. Pope, Qingsong Xia, Virginia Paton et al. · Neurology · 2011 · 121 citations

Medicine, Neurology, Oncology +17

Literature survey of on-line elemental speciation in aqueous solutions

Arabinda K. Das · Talanta · 2001 · 97 citations

Natural Sciences, Chemical Engineering, Chemistry +16